Estrella Immunopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Estrella Immunopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q3 2024.
  • Estrella Immunopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 20, 2024 was 36.2M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 36.2M Sep 20, 2024 10-K 2024-09-27
Q1 2024 36.4M +34M +1461% May 13, 2024 10-Q 2024-05-15
Q4 2023 36.6M Feb 12, 2024 10-Q 2024-02-14
Q2 2023 2.17M -3.68M -62.9% Jul 31, 2023 10-Q 2023-08-01
Q1 2023 2.33M -3.52M -60.2% Mar 14, 2023 10-K 2023-03-14
Q3 2022 5.85M 0 0% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 5.85M Aug 8, 2022 10-Q 2022-08-08
Q1 2022 5.85M Mar 29, 2022 10-K 2022-03-29
Q3 2021 5.85M Nov 10, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.